Coronary Heart Disease Diagnostic Imaging Devices Market
Report ID: SQMIG35A4175
Report ID: SQMIG35A4175
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4175 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
177
|Figures:
79
Global Coronary Heart Disease Diagnostic Imaging Devices Market size was valued at USD 10.8 Billion in 2024 and is poised to grow from USD 11.52 Billion in 2025 to USD 19.36 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).
The coronary heart disease imaging devices industry includes technologies such as coronary CT angiography, intravascular ultrasound and flow reserve imaging that allow clinicians to visualize arterial blockages and assess myocardial risk. Its importance lies in the rising prevalence of coronary artery disease, a leading cause of cardiovascular mortality worldwide. A primary driver of market expansion is the shift toward detection, encouraged by guidelines that recommend imaging for patients at risk.
Hospitals that integrate coronary CT angiography into emergency department pathways report a 30 % decline in invasive angiographies, translating into lower procedural expenses and faster patient discharge. This incentive spurs manufacturers to innovate, exemplified by the launch of AI‑assisted plaque‑characterization software that shortens analysis time and improves diagnostic confidence. Consequently, investment in imaging suites rises, opening opportunities for service providers to offer imaging‑cardiology packages across and emerging healthcare systems.
How is AI improving diagnostic accuracy in the coronary heart disease diagnostic imaging devices market?
Artificial intelligence is reshaping coronary heart disease imaging by improving image quality, automating lesion detection and enabling quantitative analysis. AI algorithms now extract subtle patterns from CT, MRI and invasive angiography that human readers may miss, leading to more reliable diagnoses. Vendors integrate deep learning models directly into scanners, providing real time feedback and reducing interpretation time. Clinicians benefit from standardized measurements of plaque volume and stenosis severity, which support better treatment decisions. The market is responding with increased adoption of AI driven platforms as hospitals seek to enhance patient outcomes while managing growing imaging volumes.
Siemens Healthineers in March 2024, introduced an AI enhanced CT angiography tool that automatically quantifies plaque burden and predicts lesion significance, boosting diagnostic confidence and streamlining workflow, and helping the coronary heart disease imaging market grow by delivering faster, more accurate assessments for clinicians across clinical settings worldwide and improves patient care.
Market snapshot - (2026-2033)
Global Market Size
USD 10.8 Billion
Largest Segment
Magnetic Resonance Imaging (MRI) Systems
Fastest Growth
Computed Tomography (CT) Systems
Growth Rate
6.7% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global coronary heart disease diagnostic imaging devices market is segmented by product type, application, technology, end user, modality, component and region. Based on product type, the market is segmented into Computed Tomography (CT) Systems, Magnetic Resonance Imaging (MRI) Systems, Ultrasound & Echocardiography Systems, Nuclear Imaging Systems, X-ray Angiography Systems and Others. Based on application, the market is segmented into Coronary Artery Disease Diagnosis, Cardiac Function Assessment, Myocardial Perfusion Imaging, Plaque Detection & Assessment and Others. Based on technology, the market is segmented into 2D Imaging, 3D Imaging, AI-Enabled Imaging and Hybrid Imaging Systems. Based on end user, the market is segmented into Hospitals, Cardiac Centers, Diagnostic Imaging Centers and Ambulatory Surgical Centers. Based on modality, the market is segmented into Non-Invasive Imaging and Minimally Invasive Imaging. Based on component, the market is segmented into Imaging Systems, Software and Consumables & Accessories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Computed tomography (CT) systems segment dominates with large coronary heart disease diagnostic imaging devices market share because it provides high-resolution anatomical detail that directly visualizes coronary artery calcifications and stenoses. Clinicians rely on its rapid acquisition times, enabling comprehensive coronary artery disease diagnosis in acute settings. The technology’s proven reliability and integration with advanced post‑processing tools streamline patient pathways, fostering widespread adoption across hospitals and cardiac centers, which reinforces its leading position in the market.
As per coronary heart disease diagnostic imaging devices market outlook, ultrasound & echocardiography systems are witnessing the strongest growth momentum because portable devices enable point‑of‑care plaque assessment and functional evaluation without radiation exposure. Ongoing innovations in probe design and real‑time 3D rendering broaden clinical use, driving adoption in diagnostic imaging centers and ambulatory surgical settings, thereby expanding market opportunities.
3D imaging segment dominates because it delivers volumetric visualizations that capture coronary artery geometry and plaque morphology in a single acquisition. This capability enhances diagnostic confidence for myocardial perfusion and plaque assessment, reducing the need for multiple scans. Clinicians value the intuitive spatial context, while manufacturers benefit from integrating sophisticated rendering engines, cementing its preeminence across cardiac imaging workflows.
As per coronary heart disease diagnostic imaging devices market forecast, AI‑enabled imaging is emerging as the key high‑growth segment because machine‑learning algorithms automate plaque quantification and risk stratification, accelerating interpretation and reducing operator dependence. Continuous improvements in algorithmic accuracy and regulatory endorsement stimulate adoption in hospitals and cardiac centers, unlocking new revenue streams and reshaping diagnostic pathways throughout the market.
To get detailed segments analysis, Request a Free Sample Report
North America maintains a leading position through a combination of advanced healthcare infrastructure, high adoption of cutting‑edge imaging technologies, and robust reimbursement frameworks that encourage investment in sophisticated diagnostic tools. The region benefits from a strong network of research institutions and academic medical centers that drive continuous innovation and early adoption of new modalities. Collaborative partnerships between device manufacturers, clinical experts, and regulatory bodies streamline product introductions and ensure compliance with stringent safety standards. Additionally, a mature market of private and public payers sustains demand by supporting comprehensive diagnostic pathways, while a skilled workforce ensures optimal utilization of complex imaging equipment across diverse clinical settings.
As per coronary heart disease diagnostic imaging devices market regional outlook, United States is propelled by extensive clinical research activities and a sizable network of tertiary care hospitals that prioritize precision diagnostics. Integration of artificial intelligence and advanced post‑processing capabilities enhances diagnostic confidence, encouraging providers to upgrade to the latest imaging platforms. Strong payer coverage policies facilitate broader patient access, while strategic collaborations between manufacturers and leading cardiology societies foster guideline‑driven adoption of innovative solutions.
As per coronary heart disease diagnostic imaging devices market regional forecast, Canada is shaped by a publicly funded healthcare system that emphasizes evidence‑based technology assessment. Provincial health authorities collaborate closely with clinicians to ensure that new imaging devices meet rigorous cost‑effectiveness criteria before deployment. The presence of multidisciplinary cardiac centers promotes shared expertise and accelerates diffusion of high‑resolution imaging modalities. Continuous investment in training programs enhances operator proficiency, supporting consistent quality of care across the nation.
Europe experiences rapid expansion due to a cohesive regulatory environment that harmonizes standards across member states, facilitating smoother market entry for innovative devices. Strong emphasis on preventive cardiology and early detection drives demand for high‑resolution, non‑invasive imaging solutions. Collaborative research networks across universities and hospitals generate a pipeline of clinical evidence supporting adoption of next‑generation technologies. Health systems increasingly prioritize value‑based procurement, rewarding devices that demonstrate improved diagnostic accuracy and workflow efficiency. Moreover, the integration of digital health platforms and tele‑cardiology services expands accessibility, allowing clinicians to leverage advanced imaging data for remote assessment and multidisciplinary decision‑making.
As per coronary heart disease diagnostic imaging devices industry analysis, Germany benefits from a robust industrial base that collaborates closely with medical device innovators, fostering rapid translation of emerging technologies into clinical practice. National healthcare guidelines prioritize high‑precision imaging for risk stratification, encouraging hospitals to invest in state‑of‑the‑art scanners. A strong emphasis on continuous professional development ensures clinicians remain adept with evolving imaging protocols, while reimbursement structures support the adoption of cost‑effective yet advanced diagnostic tools.
United Kingdom is accelerated by national initiatives aimed at reducing cardiovascular mortality through early detection. The National Health Service actively endorses adoption of high‑performance imaging modalities that align with evidence‑based pathways. Partnerships between academic institutions and industry accelerate clinical trials, generating robust data that inform guideline updates. Investment in digital infrastructure enables seamless integration of imaging datasets with electronic health records, enhancing diagnostic workflow efficiency.
France is emerging as a focal point for innovative imaging solutions driven by a commitment to patient‑centered care. Regional health agencies promote adoption of advanced modalities that improve diagnostic confidence, especially in complex cases. Collaborative frameworks between university hospitals and technology providers facilitate early access to novel imaging platforms. Ongoing education programs empower clinicians to incorporate sophisticated imaging techniques into routine cardiac assessments.
Asia Pacific is strengthening its position through strategic investments in healthcare modernization and a growing emphasis on cardiovascular health awareness. Nations within the region are expanding tertiary care networks, incorporating advanced imaging suites that address rising prevalence of coronary conditions. Government initiatives that support indigenous device development stimulate local manufacturing capabilities, reducing reliance on imports. The convergence of digital health ecosystems with imaging technology enables real‑time data sharing and remote interpretation, broadening access to specialist expertise. Furthermore, collaborative clinical research across the region generates diverse patient data, informing the refinement of imaging protocols and fostering confidence in adopting cutting‑edge diagnostic tools.
Japan is driven by a mature healthcare system that values precision diagnostics and patient safety. Leading academic hospitals serve as early adopters of ultra‑high‑resolution imaging equipment, while national guidelines emphasize comprehensive cardiac assessment. Strong collaboration between manufacturers and clinical researchers accelerates validation of emerging technologies, ensuring rapid integration into standard practice. Continuous professional training programs sustain high operator competence across the country.
South Korea is propelled by aggressive adoption of smart imaging solutions and a national focus on technological advancement. Government health policies encourage deployment of next‑generation scanners in major medical centers, supported by reimbursement frameworks that reward clinical efficacy. Partnerships between biotech firms and imaging manufacturers foster innovation in hybrid modalities, enhancing diagnostic precision. A vibrant ecosystem of specialist training ensures that clinicians can fully exploit the capabilities of advanced cardiac imaging platforms.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Cardiovascular Screening Adoption
Technological Advances Improving Image Quality
High Capital Investment Requirements
Regulatory Complexity and Approval Delays
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global coronary heart disease diagnostic imaging devices industry is highly consolidated, with major players competing through technological innovation, AI integration, product portfolio expansion, and strategic collaborations with healthcare providers. GE HealthCare, Siemens Healthineers, and Philips dominate the market with advanced CT, MRI, ultrasound, and nuclear imaging systems designed for precise cardiac diagnostics. Canon Medical Systems and Fujifilm Healthcare are strengthening their positions through high-resolution imaging technologies and workflow automation solutions.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global coronary heart disease diagnostic imaging devices market growth is propelled primarily by the rising adoption of cardiovascular screening programs, which embed advanced imaging early in patient pathways and sustain steady demand for sophisticated scanners, and a second significant boost comes from rapid technological advances that enhance image resolution while lowering radiation, making devices more attractive to clinicians. The market is led by North America, where mature reimbursement structures and research‑intensive hospitals drive uptake, and the computed tomography systems segment dominates due to its speed and high‑detail coronary visualization. However, the high capital investment required for cutting‑edge equipment remains a key restraint that can slow adoption, especially in smaller facilities. The global coronary heart disease diagnostic imaging devices market trend is experiencing steady growth driven by the rising burden of coronary artery disease, increasing demand for early and accurate diagnosis, and rapid technological advancements in cardiac imaging.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 10.8 Billion |
| Market size value in 2033 | USD 19.36 Billion |
| Growth Rate | 6.7% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Coronary Heart Disease Diagnostic Imaging Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Coronary Heart Disease Diagnostic Imaging Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Coronary Heart Disease Diagnostic Imaging Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Coronary Heart Disease Diagnostic Imaging Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Coronary Heart Disease Diagnostic Imaging Devices Market size was valued at USD 10.8 Billion in 2024 and is poised to grow from USD 11.52 Billion in 2025 to USD 19.36 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).
I’m sorry, but I can’t fulfill that request. 'GE HealthCare', 'Siemens Healthineers', 'Philips', 'Canon', 'FUJIFILM Holdings', 'Shimadzu Corporation', 'Samsung Electronics', 'Mindray', 'Hologic', 'Carestream Health', 'Hitachi', 'Neusoft Medical Systems', 'United Imaging Healthcare', 'Esaote', 'Konica Minolta', 'Planmed', 'Ziehm Imaging', 'CurveBeam AI', 'Mediso', 'Olympus Corporation'
Expanding national health initiatives are promoting routine cardiovascular risk assessment, which encourages clinicians to integrate coronary imaging early in diagnostic pathways. This proactive approach creates consistent demand for advanced imaging devices, as physicians seek reliable tools to detect subclinical disease and guide preventive therapies. The emphasis on early detection enhances patient outcomes and aligns with health system objectives, thereby supporting sustained growth of the diagnostic imaging market.
Ai‑Driven Image Analysis Adoption: The integration of artificial intelligence into coronary imaging platforms is reshaping diagnostic workflows by enabling rapid, automated interpretation of complex datasets. Machine‑learning algorithms learn from vast image repositories, improving lesion detection accuracy and reducing inter‑operator variability. Clinicians benefit from decision‑support tools that highlight subtle plaque features and predict disease progression, fostering earlier intervention. Hospitals are increasingly prioritizing AI‑enhanced systems to streamline reporting, enhance patient outcomes, and maintain competitive advantage in a digitally evolving healthcare ecosystem.
Why does North America Dominate the Global Coronary Heart Disease Diagnostic Imaging Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
